CD274 and neoplasm: In this work, we demonstrated that combining anti-PD-L1 mAb with anti-4-1BB mAb treatment resulted in a significant tumor abrogation in 3LL model and a decrease of lung MT in 4T1.2 model, whereas 4-1BB agonism or PD-L1 blockade alone had none or only modest effects.